Li YD - Search Results

1

Research progress in overcoming ibrutinib drug resistance.

Ma XY, Zhao M, Li YD, Chen Y, Wei L, Chen ZS. Ma XY, et al. Among authors: li yd. Drugs Today (Barc). 2022 Feb;58(2):85-94. doi: 10.1358/dot.2022.58.2.3360405. Drugs Today (Barc). 2022. PMID: 35188143

2

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer.

Zhang L, Li Y, Wang Q, Chen Z, Li X, Wu Z, Hu C, Liao D, Zhang W, Chen ZS. Zhang L, et al. Mol Cancer. 2020 Jan 17;19(1):10. doi: 10.1186/s12943-019-1112-1. Mol Cancer. 2020. PMID: 31952518 Free PMC article.

3

Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells.

Li YD, Mao Y, Dong XD, Lei ZN, Yang Y, Lin L, Ashby CR Jr, Yang DH, Fan YF, Chen ZS. Li YD, et al. Front Oncol. 2020 Jun 26;10:932. doi: 10.3389/fonc.2020.00932. eCollection 2020. Front Oncol. 2020. PMID: 32676451 Free PMC article.

4

Bruton's Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells.

Dong XD, Zhang M, Ma X, Wang JQ, Lei ZN, Teng QX, Li YD, Lin L, Feng W, Chen ZS. Dong XD, et al. Among authors: li yd. Front Cell Dev Biol. 2020 Aug 27;8:865. doi: 10.3389/fcell.2020.00865. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32984343 Free PMC article.

5

CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10).

Wang JQ, Wang B, Teng QX, Lei ZN, Li YD, Shi Z, Ma LY, Liu HM, Liu Z, Chen ZS. Wang JQ, et al. Among authors: li yd. Biochem Pharmacol. 2021 Aug;190:114652. doi: 10.1016/j.bcp.2021.114652. Epub 2021 Jun 11. Biochem Pharmacol. 2021. PMID: 34126072

6

ATP-binding cassette (ABC) transporters in cancer: A review of recent updates.

Wang JQ, Wu ZX, Yang Y, Teng QX, Li YD, Lei ZN, Jani KA, Kaushal N, Chen ZS. Wang JQ, et al. Among authors: li yd. J Evid Based Med. 2021 Sep;14(3):232-256. doi: 10.1111/jebm.12434. Epub 2021 Aug 13. J Evid Based Med. 2021. PMID: 34388310 Review.

7

Extracellular Vesicles in Acute Leukemia: A Mesmerizing Journey With a Focus on Transferred microRNAs.

Izadirad M, Huang Z, Jafari F, Hamidieh AA, Gharehbaghian A, Li YD, Jafari L, Chen ZS. Izadirad M, et al. Among authors: li yd. Front Cell Dev Biol. 2021 Oct 6;9:766371. doi: 10.3389/fcell.2021.766371. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34692712 Free PMC article. Review.

8

Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells.

Zhang L, Ye B, Lin Y, Li YD, Wang JQ, Chen Z, Ping FF, Chen ZS. Zhang L, et al. Among authors: li yd. Front Pharmacol. 2022 Apr 1;13:867128. doi: 10.3389/fphar.2022.867128. eCollection 2022. Front Pharmacol. 2022. PMID: 35450042 Free PMC article.

9

CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells.

Zhang L, Li Y, Hu C, Chen Y, Chen Z, Chen ZS, Zhang JY, Fang S. Zhang L, et al. Mol Cancer. 2022 Apr 22;21(1):103. doi: 10.1186/s12943-022-01524-w. Mol Cancer. 2022. PMID: 35459184 Free PMC article.

10

The Roles of Exosomal microRNAs in Diffuse Large B-Cell Lymphoma: Diagnosis, Prognosis, Clinical Application, and Biomolecular Mechanisms.

Yazdanparast S, Huang Z, Keramat S, Izadirad M, Li YD, Bo L, Gharehbaghian A, Chen ZS. Yazdanparast S, et al. Among authors: li yd. Front Oncol. 2022 Jun 2;12:904637. doi: 10.3389/fonc.2022.904637. eCollection 2022. Front Oncol. 2022. PMID: 35719983 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters